Home > Financial Ratios > LAURUS LABS
COMMUNITY POLL
for LAURUS LABS
Please provide your vote to see the results

LAURUS LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 40.62-49.7011.16-8.68175.97

What is the latest Core EBITDA Growth ratio of LAURUS LABS ?

The latest Core EBITDA Growth ratio of LAURUS LABS is 40.62 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202540.62
Mar2024-49.70
Mar202311.16
Mar2022-8.68
Mar2021175.97

How is Core EBITDA Growth of LAURUS LABS Trending?

Years Core EBITDA Growth % Change
Mar2025 40.62
Positive
Mar2024 -49.7
Negative
Mar2023 11.16
Positive
Mar2022 -8.68
Negative
Mar2021 175.97 -

Other Financial Ratios of LAURUS LABS


Compare Core EBITDA Growth ratio of peers of LAURUS LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LAURUS LABS ₹51,523.9 Cr 1.5% 13.4% 96.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,452.0 Cr -0.3% 6% -10.5% Stock Analytics
DIVIS LABORATORIES ₹179,089.0 Cr 3.9% 18.6% 14.5% Stock Analytics
CIPLA ₹121,299.0 Cr -5.2% NA 2.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,456.0 Cr -1% -1.2% 8.7% Stock Analytics
DR REDDYS LABORATORIES ₹99,965.9 Cr -6.8% -2.1% -8.4% Stock Analytics


LAURUS LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LAURUS LABS

1.5%

13.4%

96.8%

SENSEX

-0.3%

4.5%

5.7%


You may also like the below Video Courses